Summit Eye Center strives to provide the latest treatment options to our patients. Yesterday, Dr. Skelsey performed his first Hydrus Microstent procedures. In doing so, our patients are among the first in the Midwest to receive this innovative glaucoma treatment.
The Hydrus Microstent is the world’s first “intracanalicular scaffold” for the treatment of glaucoma. Roughly the size of an eyelash, it is made from a super-elastic, biocompatible alloy, which has been used in over 1 million implants in a variety of medical devices throughout the body.